The second study was performed by Tazzite et al. [29] on a Moroccan cohort of 40 women, diagnosed with BC and a familial history of breast/ovarian cancer, or aged less than 40 years old showed that 25.64% of patients carried BRCA1/2 mutations. The gene discussed is BRCA1; the disease is ovarian cancer.